Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.

Mei YP, Zhou JM, Wang Y, Huang H, Deng R, Feng GK, Zeng YX, Zhu XF.

Cell Cycle. 2007 Jun 1;6(11):1379-85. Epub 2007 Jun 11.

PMID:
17507800
2.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217
3.
4.

Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.

Zheng H, Li LL, Hu DS, Deng XY, Cao Y.

Cell Mol Immunol. 2007 Jun;4(3):185-96. Review.

5.
6.
7.

Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.

Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J.

Oncogene. 2003 Apr 17;22(15):2260-71.

PMID:
12700662
8.

Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.

Li SS, Yang S, Wang S, Yang XM, Tang QL, Wang SH.

Oncol Rep. 2011 Dec;26(6):1573-9. doi: 10.3892/or.2011.1423. Epub 2011 Aug 17.

PMID:
21850380
9.

Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.

Chung GT, Lou WP, Chow C, To KF, Choy KW, Leung AW, Tong CY, Yuen JW, Ko CW, Yip TT, Busson P, Lo KW.

J Pathol. 2013 Nov;231(3):311-22. doi: 10.1002/path.4239. Epub 2013 Sep 3.

PMID:
23868181
10.

Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.

Sung WW, Chu YC, Chen PR, Liao MH, Lee JW.

Cancer Lett. 2016 Nov 1;382(1):21-31. doi: 10.1016/j.canlet.2016.08.021. Epub 2016 Aug 24.

PMID:
27567526
11.
12.

EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.

Chang PY, Wu ZZ, Sun NK, Chao CC.

J Cell Physiol. 2014 Mar;229(3):309-22. doi: 10.1002/jcp.24448.

PMID:
23939952
13.
14.

Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.

Yang GD, Huang TJ, Peng LX, Yang CF, Liu RY, Huang HB, Chu QQ, Yang HJ, Huang JL, Zhu ZY, Qian CN, Huang BJ.

PLoS One. 2013 Oct 23;8(10):e78355. doi: 10.1371/journal.pone.0078355. eCollection 2013.

15.
17.

Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.

Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, Navarro-Martín A, Poitevin-Chacón A.

Arch Med Res. 2014 Apr;45(3):229-36. doi: 10.1016/j.arcmed.2014.02.002. Epub 2014 Mar 4.

PMID:
24606815
18.

Modulation of LMP1 protein expression by EBV-encoded microRNAs.

Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16164-9. Epub 2007 Oct 2.

19.

Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.

Hau PM, Tsang CM, Yip YL, Huen MS, Tsao SW.

PLoS One. 2011;6(6):e21176. doi: 10.1371/journal.pone.0021176. Epub 2011 Jun 20.

20.

Supplemental Content

Support Center